Výsledky vyhledávání - "Robert F. Shoemaker"

Abstract 2672: ERAS-007 is a selective ERK1/2 inhibitor with preclinical activity across RAS/MAPK pathway-driven CRC models

Autor: Erin D. Lew, Joanne Oh, Taylor Congdon, Jingchuan Zhang, Robert F. Shoemaker

Publikováno v: Cancer Research. 82:2672-2672

Colorectal cancer (CRC) remains an unmet medical need where more than 50% off patients have tumors that are driven by somatic mutations in the RAS/MAPK signaling pathway. Targeted therapies, such as anti-EGFR inhibitors for patients with BRAFwt/RASwt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3449c5f620b7f5adda03d89d616c95e9
https://doi.org/10.1158/1538-7445.am2022-2672

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání